Journal
MOLECULAR ONCOLOGY
Volume 15, Issue 12, Pages 3596-3614Publisher
WILEY
DOI: 10.1002/1878-0261.13110
Keywords
ascites; chemotherapy; extracellular matrix; extracellular vesicles; fibronectin; ovarian cancer
Categories
Funding
- Ministry of Health '5 per mille anno 2016' Grant
- European Community [FETOPEN-801367, FETPROACT-EIC-05-2019]
- Bando POR FESR
Ask authors/readers for more resources
The study characterized ascites from high-grade epithelial ovarian cancer patients and found that small-EVs from different sources exhibited significantly different stiffness and size distributions, as well as distinct proteomic profiles. Small-EVs derived from ascites cell cultures contained extracellular matrix remodeling regulators, while those from bulk ascitic fluid were predominantly involved in the complement and coagulation cascade. This study demonstrates the importance of an ascites cell isolation workflow in investigating the treatment-induced cancer adaption processes.
The exact role of malignant ascites in the development of intraperitoneal metastases remains unclear, and the mechanisms by which extracellular vesicles (EVs) promote tumor progression in the pre-metastatic niche have not been fully discovered. In this study, we characterized ascites from high-grade epithelial ovarian cancer patients. Small-EVs (30-150 nm) were isolated from two sources-the bulk ascites and the ascitic fluid-derived tumor cell cultures-and assessed with a combination of imaging, proteomic profiling, and protein expression analyses. In addition, Gene Ontology and pathway analysis were performed using different databases and bioinformatic tools. The results proved that the small-EVs derived from the two sources exhibited significantly different stiffness and size distributions. The bulk ascitic fluid-derived small-EVs were predominantly involved in the complement and coagulation cascade. Small-EVs derived from ascites cell cultures contained a robust proteomic profile of extracellular matrix remodeling regulators, and we observed an increase in transforming growth factor-beta-I (TGF beta I), plasminogen activator inhibitor 1 (PAI-1), and fibronectin expression after neoadjuvant chemotherapy. When measured in the two sources, we demonstrated that fibronectin exhibited opposite expression patterns in small-EVs in response to chemotherapy. These findings highlight the importance of an ascites cell isolation workflow in investigating the treatment-induced cancer adaption processes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available